83032-001-02 : NDC 2026 Code

83032-001-02 : Regadenoson ( Regadenoson )

Additionally :

You can get information about “83032-001-02” NDC code in 83032-001-02 in HTML format

HTML | 83032-001-02 in TXT (Plain Text) format

TXT | 83032-001-02 in PDF (Portable Document Format)

PDF | 83032-001-02 in XML format

XML formats.

NDC Code : 83032-001-02 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "83032-001-02",
    "PackageDescription": "1 SYRINGE in 1 CARTON (83032-001-02)  / 5 mL in 1 SYRINGE",
    "NDC11Code": "83032-0001-02",
    "ProductNDC": "83032-001",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Regadenoson",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Regadenoson",
    "DosageFormName": "INJECTION, SOLUTION",
    "RouteName": "INTRAVENOUS",
    "StartMarketingDate": "20240822",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA218054",
    "LabelerName": "Indies Pharma Jamaica Limited",
    "SubstanceName": "REGADENOSON",
    "StrengthNumber": ".08",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": "Adenosine Receptor Agonists [MoA], Pharmacologic Cardiac Stress Test Agent [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-12-29",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20240822",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}